Clinical trial

AUGMENTIN 1gm In Skin And Soft Tissue Infection

NCT00343135 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00343135
Title AUGMENTIN 1gm In Skin And Soft Tissue Infection
Official title An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Skin Diseases, Infectious, Infection, Soft Tissue
Intervention type Drug
Interventions amoxicillin/clavulanate potassium 1gm
Enrollment 195
Start date Dec 1, 2004
Primary completion Mar 1, 2005
Completion Mar 1, 2005
First posted Jun 22, 2006
Last update posted Nov 22, 2012
Countries Pakistan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies